The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

被引:0
|
作者
Mark Tuthill
Frederick Chen
Samantha Paston
Hugo De La Peña
Sylvie Rusakiewicz
Alejandro Madrigal
机构
[1] The Anthony Nolan Research Institute,
[2] Royal Free Hospital,undefined
来源
关键词
CMV; Vaccine; Adoptive cellular therapy; Artificial antigen presenting cells;
D O I
暂无
中图分类号
学科分类号
摘要
Allogeneic haematopoietic stem cell transplantation (HSCT) is an intensive medical treatment involving myeloablative chemo-radiotherapy followed by stem cell rescue using allogeneic haematopoietic stem cells harvested from HLA-matched donors, which is primarily used for the treatment of haematological malignancies. Cytomegalovirus (CMV) infection is one of the major causes of morbidity and death after HSCT. This focused research review highlights the advances made with research into CMV in the HSCT setting. It provides the reader with an overview of current CMV research into the prevention and management of CMV infection.
引用
收藏
页码:1481 / 1488
页数:7
相关论文
共 50 条
  • [41] Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
    Paolo A. Muraro
    Roland Martin
    Giovanni Luigi Mancardi
    Richard Nicholas
    Maria Pia Sormani
    Riccardo Saccardi
    Nature Reviews Neurology, 2017, 13 : 391 - 405
  • [42] Autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
    Loh, Yvonne S. M.
    Hwang, William Y. K.
    Ratnagopal, Pavanni
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2007, 36 (06) : 421 - 426
  • [43] Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation Diagnosis and Treatment
    Choi, Cecilia M.
    Schmaier, Alvin H.
    Snell, Michael R.
    Lazarus, Hillard M.
    DRUGS, 2009, 69 (02) : 183 - 198
  • [45] Prevention of Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation: Preemptive Therapy Vs Universal Prophylaxis
    Mossad, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E329 - E329
  • [46] Prevention and treatment of bacterial infections in patients with haematological cancers and haematopoietic stem cell transplantation: headways and shortcomings
    Er, Ahmet Gorkem
    Aslan, Abdullah Tarik
    Mikulska, Malgorzata
    Akova, Murat
    CLINICAL MICROBIOLOGY AND INFECTION, 2025, 31 (01) : 24 - 28
  • [47] Autologous haematopoietic stem cell transplantation for the treatment of multiple myeloma
    Tarabar, O
    Tukic, L
    Stamatovic, D
    Elez, M
    Glavicic, V
    Simic, L
    Balint, B
    Marjanovic, S
    BONE MARROW TRANSPLANTATION, 2006, 37 : S349 - S349
  • [48] Clostridium difficile infection following haematopoietic stem cell transplantation in children
    Alanazi, A.
    Doyle, J.
    Allen, U.
    Richardson, S.
    Egeler, M.
    Gassas, A.
    Schechter, T.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S134 - S134
  • [49] Varicella zoster virus infection after haematopoietic stem cell transplantation
    Choi, M. K.
    Kim, K.
    Hong, J. Y.
    Kim, K. H.
    Jung, C. W.
    Kim, W. S.
    Jang, J. H.
    Kang, W. K.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S268 - S268
  • [50] Prevention and treatment of conventional respiratory virus (CRV) infections in adult recipients of haematopoietic stem cell transplantation
    Magallanes, I
    Net, P
    Romero, T
    Sanosa, M
    Martino, R
    BONE MARROW TRANSPLANTATION, 2004, 33 : S291 - S292